Results 91 to 100 of about 7,168 (203)

Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia

open access: yesInfection and Drug Resistance, 2012
Diego J Maselli1, Juan F Fernandez1, Christine Y Whong2, Kelly Echevarria1,3, Anoop M Nambiar1,3, Antonio Anzueto1,3, Marcos I Restrepo1,3,41University of Texas Health Science Center, San Antonio, Texas, 2Memorial Hermann – Texas Medical Center,
Maselli DJ   +6 more
doaj  

In vitro activity of ceftaroline against bacterial isolates causing skin and soft tissue and respiratory tract infections collected in Latin American countries, ATLAS program 2016–2020

open access: yesJournal of Global Antimicrobial Resistance
: Objectives: Ceftaroline, a broad-spectrum cephalosporin, has activity against Gram-positive and several Gram-negative bacteria (GNB). This study aimed to evaluate the antimicrobial activity of ceftaroline and comparators against isolates causing skin ...
Naglaa Mohamed   +5 more
doaj   +1 more source

In vitro and in vivo evaluation of cephalosporins for the treatment of Lyme disease. [PDF]

open access: yes, 2018
BackgroundLyme disease accounts for >90% of all vector-borne disease cases in the United States and affect ~300,000 persons annually in North America.
Ambati, Aditya   +9 more
core  

Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe [PDF]

open access: yes, 2018
International ...
Gandra, S   +6 more
core   +3 more sources

Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter [PDF]

open access: yes, 2013
In an effort to maximize outcomes, recent expert guidelines recommend more-intensive vancomycin dosing schedules to maintain vancomycin troughs between 15 and 20 mg/liter.The widespread use of these more-intensive regimens has been associated with an ...
Lodise, T. P.   +2 more
core   +1 more source

Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections

open access: yesTherapeutics and Clinical Risk Management, 2012
Julian J Goodman, Stanley I MartinDivision of Infectious Diseases, The Ohio State University, Columbus, OH, USAAbstract: Ceftaroline is a novel broad-spectrum cephalosporin ß-lactam antibiotic with activity against methicillin-resistant ...
Goodman JJ, Martin SI
doaj  

Intravenous Solution Wastage in Hospital Pharmacy at Baptist Memorial Hospital-North Mississippi (Oxford) [PDF]

open access: yes, 2017
Introduction: IV solution wastage refers to IV medications made for a patient that remain unused by that patient for a variety of reasons, and have subsequently expired, or for other reasons cannot be used for another patient (recycled), and therefore ...
Zhang, Yujing
core   +1 more source

Spotlight commentary: Changes in pharmacokinetics following significant weight loss

open access: yes
British Journal of Clinical Pharmacology, Volume 91, Issue 3, Page 678-680, March 2025.
Andrej Belančić   +1 more
wiley   +1 more source

Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia

open access: yesTherapeutics and Clinical Risk Management, 2015
Mbiye A Mpenge,1 Alasdair P MacGowan2 1Department of Medical Microbiology, University Hospitals Bristol NHS Trust, Bristol Royal Infirmary, Bristol, England; 2Department of Medical Microbiology, North Bristol NHS Trust, Southmead Hospital, Bristol ...
Mpenge MA, MacGowan AP
doaj  

Ceftaroline Fosamil for the Treatment of Methicillin-Resistant Staphylococcus Aureus Bacteremia: A Real-World Comparative Clinical Outcomes Study

open access: yesDrugs - Real World Outcomes
Background and Objective Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia results in substantial morbidity and mortality. As current treatments often lead to unsatisfactory outcomes, evidence guiding alternative treatment options is needed ...
Jennifer Hammond   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy